DWM
ARCT icon

Diversify Wealth Management’s Arcturus Therapeutics ARCT Stock Holding History

Diversify Wealth Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.9K Hold
15,785
– – ﹤0.01% 1226
2026
Q1 		$133K Buy
+15,785
New +$115K ﹤0.01% 1113

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Diversify Wealth Management's ARCT Position: Q2 2026 in Review

Diversify Wealth Management held its Arcturus Therapeutics (ARCT) position steady in Q2 2026 at 15,785 shares worth $90.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

Diversify Wealth Management first reported a position in ARCT in Q1 2026 and has held it in 2 quarters since. The position peaked at $133K in Q1 2026. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Diversify Wealth Management held 15,785 shares of Arcturus Therapeutics worth $90.9K as of Q2 2026.
  • Diversify Wealth Management left its Arcturus Therapeutics share count unchanged in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Diversify Wealth Management's portfolio in Q2 2026, its #1226 holding.
  • Diversify Wealth Management first reported a position in Arcturus Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Diversify Wealth Management's Arcturus Therapeutics position peaked at $133K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.